A laccase–mediator system based on caffeic acid for the synthesis of benzimidazoles

AI Insight

This study describes the development of a laccase-mediator system (LMS) using caffeic acid as a natural mediator to facilitate the enzymatic synthesis of benzimidazoles, a class of heterocyclic compounds with broad pharmaceutical relevance. The system leverages the oxidative capacity of laccase, a copper-containing enzyme, enhanced by caffeic acid to catalyze the oxidative cyclization reactions required to form the benzimidazole scaffold under mild, environmentally friendly conditions. This biocatalytic approach offers an alternative to conventional chemical synthesis routes that typically require harsh reagents and conditions.

Why it matters

Benzimidazoles are core structures in numerous drugs, agrochemicals, and bioactive molecules, so a greener enzymatic route to their synthesis could reduce the environmental footprint of pharmaceutical manufacturing and open pathways for sustainable production of valuable compounds.